Order Article Reprints

Galdeano C, Coquelle N, Cieslikiewicz-Bouet M, Bartolini M, Pérez B, Clos MV, Silman I, Jean L, Colletier J-P, Renard P-Y, et al. Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules. 2018; 23(3):634. https://doi.org/10.3390/molecules23030634

Galdeano, Carles, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Manuela Bartolini, Belén Pérez, M. Victòria Clos, Israel Silman, Ludovic Jean, Jacques-Philippe Colletier, Pierre-Yves Renard, and et al. 2018. "Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis" Molecules 23, no. 3: 634. https://doi.org/10.3390/molecules23030634

Galdeano, C., Coquelle, N., Cieslikiewicz-Bouet, M., Bartolini, M., Pérez, B., Clos, M. V., Silman, I., Jean, L., Colletier, J.-P., Renard, P.-Y., & Muñoz-Torrero, D. (2018). Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules, 23(3), 634. https://doi.org/10.3390/molecules23030634